ClearBridge Mid Cap Strategy outperforms benchmark in Q3, adds QXO and Bio-Techne, exits ATS

[Woman putting savings in a white piggy bank.]
Guido Mieth

ClearBridge Mid Cap Strategy outperformed its Russell Midcap Index during the third quarter, driven by standout stock selection in consumer staples and health care.

The Strategy added a new position in QXO (NYSE:QXO [https://seekingalpha.com/symbol/QXO]), a newly formed building materials distribution platform in the industrials sector led by Brad Jacobs, and also initiated a position in Bio-Techne (NASDAQ:TECH [https://seekingalpha.com/symbol/TECH]), capitalizing on recent weakness in the name tied to uncertainty surrounding tariffs and National Institute of Health funding.

However, it exited its position in ATS Corporation (NYSE:ATS [https://seekingalpha.com/symbol/ATS]), arguing that the departure of its CEO has caused ClearBridge Mid Cap to question its expectations for further outperformance.

Heading into year-end, the strategy remains constructive on mid cap equities — though with a healthy respect for near-term volatility. "The Fed’s rate cut in September provides a potential inflection in sentiment and relief for rate-sensitive sectors."

Source [https://seekingalpha.com/article/4829689-clearbridge-mid-cap-strategy-q3-2025-commentary]

MORE ON CLEARBRIDGE MID CAP FUND CLASS I

* ClearBridge Mid Cap Strategy Q3 2025 Commentary [https://seekingalpha.com/article/4829689-clearbridge-mid-cap-strategy-q3-2025-commentary]
* Franklin Templeton ClearBridge Mid Cap Fund Q2 2025 Commentary [https://seekingalpha.com/article/4818011-franklin-templeton-clearbridge-mid-cap-fund-q2-2025-commentary]
* ClearBridge Mid Cap Portfolios Q2 2025 Commentary [https://seekingalpha.com/article/4808257-clearbridge-mid-cap-portfolios-q2-2025-commentary]
* Dividend scorecard for ClearBridge Mid Cap Fund Class I [https://seekingalpha.com/symbol/SMBYX/dividends/scorecard]